GLP-1 RA Use Not Associated With Increased Safety Risks in OUD Tags GLP-1 agonists Read more about GLP-1 RA Use Not Associated With Increased Safety Risks in OUD
Sleep Intervention Did Not Improve Overall Glycemic Outcomes in T1DM Tags hBA1c Continuous glucose monitoring (CGM) Read more about Sleep Intervention Did Not Improve Overall Glycemic Outcomes in T1DM
eGDR Outperforms Conventional IR Indices for AKI Risk Stratification Tags Diabetic Nephropathy Diabetic Nephropathy hBA1c Read more about eGDR Outperforms Conventional IR Indices for AKI Risk Stratification
CSII and AID Associated With Improved Glycemic Outcomes in Pediatric T1DM Tags Insulin syringes Others Delivery devices hBA1c Read more about CSII and AID Associated With Improved Glycemic Outcomes in Pediatric T1DM
Prediabetes-Specific Model Improves CV Death Risk Prediction Tags Coronary artery disease Read more about Prediabetes-Specific Model Improves CV Death Risk Prediction
Semaglutide Added to Insulin Improved Glycemic, Renal Measures in T2DM Tags Diabetic Nephropathy FBS GLP-1 agonists hBA1c Read more about Semaglutide Added to Insulin Improved Glycemic, Renal Measures in T2DM
High DR Incidence Observed in T2DM With Hypertension Tags Retinopathy Read more about High DR Incidence Observed in T2DM With Hypertension
SGLT2 Inhibitors Did Not Worsen LUTS in Type 2 Diabetes Tags Diabetic Nephropathy SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Did Not Worsen LUTS in Type 2 Diabetes
Albuminuria Linked to Higher 5-year Microvascular Risk in T2DM With CKD Tags Albuminuria Diabetic Neuropathy Retinopathy Read more about Albuminuria Linked to Higher 5-year Microvascular Risk in T2DM With CKD
SGLT2i Associated With Lower HHF, CV Death Risk in PAD Tags Coronary artery disease Peripheral vascular disease SGLT-2 Inhibitor Read more about SGLT2i Associated With Lower HHF, CV Death Risk in PAD